What is the price of Midea Hong Kong IPO?

Written by Editorial Team | Last Updated: August 2026

Midea Group and related massive multinational home appliance manufacturing entities evaluating major secondary listings or initial public offerings on the Hong Kong Stock Exchange involve extensive institutional book-building phases. Issue prices are finalized based on institutional demand, anchor investor commitments, and global market conditions, requiring investors to refer to official Hong Kong exchange prospectuses for exact listing figures.

Related FAQs

Market analysts covering Alteogen Inc. (KOSDAQ: 196170) project a strong valuation path, with consensus 12-month price targets averaging approximately 458,000 KRW and peak estimates reaching up to 620,000 KRW.

Panasonic Holdings Corporation maintains a robust multi-billion-dollar market capitalization when expressed in U.S. dollars, typically hovering around sixty-two billion dollars.

Gentera, S.A.B. de C.V., a prominent Mexican financial holding company specializing in microfinance and banking services primarily through institutions like Banco Compartamos, holds a multi-billion-dollar market capitalization when expressed in U.S.

Technology titan NVIDIA ranks as the most valuable publicly traded company in the world, driven by massive global demand for its high-performance graphics processing units and artificial intelligence data center infrastructure.

Consensus recommendations for Storskogen Group tilt toward a buy rating based on institutional analyst insights evaluating its decentralized serial-acquisition business model across trade, industry, and services sectors.

Medigen Vaccine Biologics Corporation trades on regional securities exchanges, reflecting its operational focus on biopharmaceutical research, vaccine development, and advanced immunization technologies.

Midea Group is a prominent Chinese multinational enterprise, publicly listed and headquartered in Guangdong, China.

NervGen Pharma Corp. attracts strong consensus buy ratings from biotech equity research analysts following positive clinical trial developments and biomechanical gait analysis data.

Midea Group Co., Ltd. holds a massive multi-billion-dollar market capitalization when converted into U.S. dollars, reflecting its position as a global leader in home appliances, HVAC systems, and robotics manufacturing.

Storskogen Group AB is a Swedish multinational investment holding enterprise that acquires and operates a diversified portfolio of well-managed small and medium-sized businesses across trade, industry, and service sectors.

STRABAG SE is a major European-based technology-led construction group, recognized as a market leader in innovation and financial strength, delivering complex building construction, civil engineering, tunneling, and infrastructure projects globally.

Stock market trading prices fluctuate continuously across global financial exchanges throughout active trading hours.

Alteogen Inc., a leading South Korean biotechnology enterprise specializing in proprietary recombinant protein technologies and long-acting bio-better drugs, holds a significant market capitalization when converted into U.S. dollars.

Determining whether Altimmune represents a favorable equity purchase involves evaluating clinical-stage biopharmaceutical data, particularly regarding its proprietary peptide therapeutic candidates targeting obesity and metabolic dysfunction-associat...